Renal Outcomes in Patients With IgA Nephropathy Undergoing Liver Transplant: A Retrospective Cohort Study

BACKGROUND: End-stage liver disease (ESLD) is the most common cause of secondary immunoglobulin A nephropathy (IgAN). Multiple mechanisms have been proposed to explain the association between liver disease and IgAN. Although some mechanisms are expected to reverse in patients after liver transplant,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hommos, Musab S., El-Zoghby, Ziad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540631/
https://www.ncbi.nlm.nih.gov/pubmed/28795144
http://dx.doi.org/10.1097/TXD.0000000000000708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540631/
https://www.ncbi.nlm.nih.gov/pubmed/28795144
http://dx.doi.org/10.1097/TXD.0000000000000708

Ejemplares similares